BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Mirum Pharmaceuticals Announces Commencement of Public Offering of Common Stock - Aug 09, 2022

  Mirum Pharmaceuticals, Inc. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell $80.0 million of shares of its common stock.

  August 9, 2022

   · 

  5 min read
• Business

  Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results

  Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the second quarter ended June 30, 2022.

  August 9, 2022

   · 

  6 min read
• Deals

  CONMED Completes Acquisition of Biorez, Inc.

  CONMED Corporation announced that it has completed its previously announced acquisition of privately-held Biorez, Inc.

  August 9, 2022

   · 

  3 min read
• Business

  Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update

  Epizyme today reported second quarter 2022 financial results and provided a business update.

  August 9, 2022

   · 

  16 min read
• Business

  NeoGenomics Reports Revenue of $125 Million in the Second Quarter

  NeoGenomics, Inc. today announced its second-quarter results for the period ended June 30, 2022.

  August 9, 2022

   · 

  25 min read
• Business

  Sensei Biotherapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights

  Sensei Biotherapeutics, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided recent business updates.

  August 9, 2022

   · 

  8 min read
• Business

  Acerus Reports Second Quarter 2022 Financial Results

  Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and six-month period ended June 30, 2022.

  August 9, 2022

   · 

  13 min read
• Business

  Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

  Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the quarter ended June 30, 2022 and provided a corporate update.

  August 9, 2022

   · 

  18 min read
• Business

  Rubius Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

  Rubius Therapeutics, Inc. (Nasdaq: RUBY), today reported second quarter 2022 financial results and provided a business update.

  August 9, 2022

   · 

  14 min read
• Business

  Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022

  Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live audio webcast on Wednesday, August 10, 2022 at 4:30 p.m. ET to report its second quarter 2022 financial results and provide an update on its business and pipeline.

  August 9, 2022

   · 

  1 min read